{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "depression",
      "neurogenesis",
      "selective serotonin reuptake inhibitor",
      "serotonin receptor"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23343901",
  "DateCompleted": {
    "Year": "2014",
    "Month": "01",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "01",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1152/jn.01093.2012"
    ],
    "Journal": {
      "ISSN": "1522-1598",
      "JournalIssue": {
        "Volume": "109",
        "Issue": "9",
        "PubDate": {
          "Year": "2013",
          "Month": "May"
        }
      },
      "Title": "Journal of neurophysiology",
      "ISOAbbreviation": "J Neurophysiol"
    },
    "ArticleTitle": "Multiple serotonergic paths to antidepressant efficacy.",
    "Pagination": {
      "StartPage": "2245",
      "EndPage": "2249",
      "MedlinePgn": "2245-9"
    },
    "Abstract": {
      "AbstractText": [
        "Depression is a leading cause of disability worldwide. Brain mechanisms underlying the clinical antidepressant efficacy of selective serotonin reuptake inhibitors (SSRI), currently the first-line treatment, remain poorly understood. Recent animal studies have implicated multiple serotonin receptor subtypes in SSRI response, opening new therapeutic perspectives."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Montreal, Qu\u00e9bec, Canada. pierreeric.lutz@gmail.com"
          }
        ],
        "LastName": "Lutz",
        "ForeName": "Pierre-Eric",
        "Initials": "PE"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Neurophysiol",
    "NlmUniqueID": "0375404",
    "ISSNLinking": "0022-3077"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents, Second-Generation"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Serotonin"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Uptake Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents, Second-Generation"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Receptors, Serotonin"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Serotonergic Neurons"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Serotonin Agents"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Selective Serotonin Reuptake Inhibitors"
    }
  ]
}